Vitro Biopharma Statistics
Total Valuation
Vitro Biopharma has a market cap or net worth of $40.29 million. The enterprise value is $41.08 million.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Vitro Biopharma has 7.33 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 7.33M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.78 |
| Forward PS | n/a |
| PB Ratio | 6.35 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 20.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 2.54 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.14 |
Financial Efficiency
Return on equity (ROE) is -66.16% and return on invested capital (ROIC) is -33.98%.
| Return on Equity (ROE) | -66.16% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -33.98% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $169,740 |
| Profits Per Employee | -$487,750 |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitro Biopharma had revenue of $2.04 million and -$5.85 million in losses. Loss per share was -$0.80.
| Revenue | 2.04M |
| Gross Profit | 2.50M |
| Operating Income | -3.18M |
| Pretax Income | -5.24M |
| Net Income | -5.85M |
| EBITDA | -4.70M |
| EBIT | -4.91M |
| Loss Per Share | -$0.80 |
Full Income StatementBalance Sheet
The company has $2.22 million in cash and $3.01 million in debt, giving a net cash position of -$791,432 or -$0.11 per share.
| Cash & Cash Equivalents | 2.22M |
| Total Debt | 3.01M |
| Net Cash | -791,432 |
| Net Cash Per Share | -$0.11 |
| Equity (Book Value) | 6.35M |
| Book Value Per Share | 0.87 |
| Working Capital | 2.71M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.53 million and capital expenditures -$211,515, giving a free cash flow of -$1.75 million.
| Operating Cash Flow | -1.53M |
| Capital Expenditures | -211,515 |
| Free Cash Flow | -1.75M |
| FCF Per Share | -$0.24 |
Full Cash Flow StatementMargins
Gross margin is 122.69%, with operating and profit margins of -156.06% and -287.35%.
| Gross Margin | 122.69% |
| Operating Margin | -156.06% |
| Pretax Margin | -257.12% |
| Profit Margin | -287.35% |
| EBITDA Margin | -230.96% |
| EBIT Margin | -241.18% |
| FCF Margin | -85.74% |
